John Strouboulis

Dr. John Strouboulis

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1998 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
PJPeter L. Jones
Peter L. Jones
GVGert Jan C Veenstra
Gert Jan C Veenstra
Paul A. WadePaul A. Wade
Paul A. Wade
DVDanielle Vermaak
Danielle Vermaak
SKStefan U. Kass
Stefan U. Kass
AWAlan P. Wolffe
Alan P. Wolffe

1 July 1994 in Immunity
Verified
Journal Article
Closed access
AMAlbrecht M. Müller
Albrecht M. Müller
AMAlexander Medvinsky
Alexander Medvinsky
John StrouboulisJohn Strouboulis
John Strouboulis
FGFrank Grosveld
Frank Grosveld
EDElaine Dzierzakt
Elaine Dzierzakt

11 June 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
EBErnie de Boer
Ernie de Boer
PRPatrick Rodriguez
Patrick Rodriguez
EBEdgar Bonte
Edgar Bonte
Jeroen KrijgsveldJeroen Krijgsveld
Jeroen Krijgsveld
EKEleni Katsantoni
Eleni Katsantoni
John StrouboulisJohn Strouboulis
John Strouboulis
Proteomic approaches require simple and efficient protein purification methodologies that are amenable to high throughput. Biotinylation is an attractive approach for protein complex purification due to the very high affinity of avidin/streptavidin for biotinylated templates. Here, we describe an approach for the single-step purification of transcription factor complex(es) based on specific in vivo biotinylation. We expressed the bacterial BirA biotin ligase in mammalian cells and demonstrated very efficient biotinylation of a hematopoietic transcription factor bearing a small (23-aa) artificial peptide tag. Biotinylation of the tagged transcription factor altered neither the factor's protein interactions or DNA binding properties in vivo nor its subnuclear distribution. Using this approach, we isolated the biotin-tagged transcription factor and at least one other known interacting protein from crude nuclear extracts by direct binding to streptavidin beads. Finally, this method works efficiently in transgenic mice, thus raising the prospect of using biotinylation tagging in protein complex purification directly from animal tissues. Therefore, BirA-mediated biotinylation of tagged proteins provides the basis for the single-step purification of proteins from mammalian cells.

1 October 1996 in Cell
Verified
Journal Article
Closed access
EMEric Milot
Eric Milot
John StrouboulisJohn Strouboulis
John Strouboulis
TTTolleiv Trimborn
Tolleiv Trimborn
MWMark Wijgerde
Mark Wijgerde
EBErnie de Boer
Ernie de Boer
PFPeter Fraser
Peter Fraser

26 May 2005 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
PRPatrick Rodriguez
Patrick Rodriguez
EBEdgar Bonte
Edgar Bonte
Jeroen KrijgsveldJeroen Krijgsveld
Jeroen Krijgsveld
KKKatarzyna E Kolodziej
Katarzyna E Kolodziej
BGBoris Guyot
Boris Guyot
John StrouboulisJohn Strouboulis
John Strouboulis
GATA‐1 is essential for the generation of the erythroid, megakaryocytic, eosinophilic and mast cell lineages. It acts as an activator and repressor of different target genes, for example, in erythroid cells it represses cell proliferation and early hematopoietic genes while activating erythroid genes, yet it is not clear how both of these functions are mediated. Using a biotinylation tagging/proteomics approach in erythroid cells, we describe distinct GATA‐1 interactions with the essential hematopoietic factor Gfi‐1b, the repressive MeCP1 complex and the chromatin remodeling ACF/WCRF complex, in addition to the known GATA‐1/FOG‐1 and GATA‐1/TAL‐1 complexes. Importantly, we show that FOG‐1 mediates GATA‐1 interactions with the MeCP1 complex, thus providing an explanation for the overlapping functions of these two factors in erythropoiesis. We also show that subsets of GATA‐1 gene targets are bound in vivo by distinct complexes, thus linking specific GATA‐1 partners to distinct aspects of its functions. Based on these findings, we suggest a model for the different roles of GATA‐1 in erythroid differentiation.

1 May 2012 in Cell Stem Cell
Verified
Journal Article
Open access
NRNicola Reynolds
Nicola Reynolds
PLPaulina Latos
Paulina Latos
AHAntony Hynes-Allen
Antony Hynes-Allen
RLRemco Loos
Remco Loos
DLDonna Leaford
Donna Leaford
BHBrian Hendrich
Brian Hendrich
Transcriptional heterogeneity within embryonic stem cell (ESC) populations has been suggested as a mechanism by which a seemingly homogeneous cell population can initiate differentiation into an array of different cell types. Chromatin remodeling proteins have been shown to control transcriptional variability in yeast and to be important for mammalian ESC lineage commitment. Here we show that the Nucleosome Remodeling and Deacetylation (NuRD) complex, which is required for ESC lineage commitment, modulates both transcriptional heterogeneity and the dynamic range of a set of pluripotency genes in ESCs. In self-renewing conditions, the influence of NuRD at these genes is balanced by the opposing action of self-renewal factors. Upon loss of self-renewal factors, the action of NuRD is sufficient to silence transcription of these pluripotency genes, allowing cells to exit self-renewal. We propose that modulation of transcription levels by NuRD is key to maintaining the differentiation responsiveness of pluripotent cells.